Delivery Order SPE2DB20D3505-SPE2DB24FU9T2

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,110.72 for the supply of 16 DRAM 1-CLIC AMBER VIALS. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,501.62 firm fixed-price delivery order is for 20 DRAM 1-CLIC AMBER VIALS, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $2,109.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, is for the procurement of 20 DRAM 1-CLIC AMBER VIALS. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of 20 DRAM 1-CLIC AMBER VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $3,550.16. The contract has an ultimate completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.09 firm fixed-price delivery order is for the procurement of 4566661564 ! 20 DRAM 1-CLIC AMBER VIALS. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,698.46 Firm Fixed Price Delivery Order contract provides 4,567,579,363 units of 16 DRAM 1-CLIC AMBER VIALS to support federal healthcare programs. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is associated with Amerisourcebergen's $999,999,999...
This federal contract award is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, which is not set aside, has a ceiling value of $1,537.48 and covers the delivery of 4,568,323,753 20 DRAM 1-CLIC AMBER VIALS. The contract has a firm fixed price pricing type and a period of performance through May 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,340.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order for 20 DRAM 1-CLIC AMBER VIALS valued at $1,096.88. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical division, and the performance period extends through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation used for this award. This contract is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $35,130.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU9T2
    Delivery Order

This federal contract award, valued at $3,130.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order, covers the supply of 16 DRAM 1-CLIC AMBER VIALS and has a completion date of September 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 2/27/25, 11:51 AM